Copy
Hep Free NYC - A Network Building Capacity to Prevent, Manage and Treat Hepatitis B & C in NYC. #HepFreeNYC
View this email in your browser
Share
Tweet
Share

Hep Free NYC

July 2015 Newsletter

In This Newsletter
New! Hep C Prevention in Youth
Social Media Campaign


2015 World Hepatitis Day NYC

NYC 2015 World Hepatitis Day Candlelight Vigil
Sunday, July 19, 2015 (7:30 - 9:00 PM). 
Washington Square Park (near the arch).

Click here to learn more about NYC commemoration of World Hepatitis Day 2015.

2015 African American Hep C Action Day NYC


July 25 is National African American Hep C Action Day! 

Plan an awareness event at your organization!
Click here to download toolkit.

Upcoming Events

HepCure Webinar | Hep C Treatment Activism. July 7th (4:30-5:30). Presentation by Tracy Swan, Hepatitis/HIV Project Director, Treatment Action Group. HepCure is a Mount Sinai production.

Webinar | Why Integrated Care Providers Must Address Viral Hepatitis. July 8 (2:00 - 3:30 PM). SAMHSA-HRSA Center for Integrated Health Solutions.

Hep-SBIRT Training: Alcohol Screening and Counseling for Hepatitis Patients. July 9 (1 PM-5 PM). 4 Hour SBIRT certification program for MD, NP, PA, LMSW/LCSW, RN.  NYC Health Dept, Long Island City. Register here

Webinar | 2015 CDC STD Guidelines: New Testing, Treatment and Disease. July 17 (12 - 1 PM).

Webinar | Consequences for Young People Who Inject Drugs: Hep C on the Rise. July 22 (10:30 - 11:45 AM).
>> View upcoming Hepatitis Community Screenings
>> See more events on our Calendar

In the News

NYC Council allocates funding to Hepatitis B & C Services in FY2016!

Public Health Groups Sue FDA For Disclosure of Clinical Trial Data for Costly Hep C Drugs. Treatment Action Group (TAG) and the Global Health Justice Partnership (GHJP) have filed a federal lawsuit to obtain access to the information that Gilead Sciences submitted to the FDA to obtain approval of two new—and extremely expensive—hepatitis C drugs, Sovaldi (sofosbuvir) and Harvoni (sofosvubir/ledipasvir).  Hepatitis C affects at least 3 million people in the United States. Sovaldi and Harvoni significantly improve cure rates, but initial pricing was unprecedented: $84,000 and $94,500 for a 12-week course of treatment, respectively.

VA to outsource care for 180,000 vets with hepatitis C. The Arizona Republic. The VA has spent weeks developing a dramatic and controversial transition as patient loads have surged and funding has run out.

China rejects patent on hepatitis C drug sofosbuvir. BMJ. The decision comes after a challenge by the Initiative for Medicines, Access and Knowledge (I-MAK), a US based group that campaigns for better access to affordable drugs.
>> See more News
Hep C Peer Navigator Story: Dennis Rivera
The NYC Council funded IDUHA Hep C Peer Navigation Program enrolled 1450 people at risk for or living with Hep C in FY2015. All enrolled were provided with Hep C prevention and health management counseling, and navigation through Hep C testing and to Hep C medical care if needed.

Tools & Resources

FAQ: Covering the Cost of Hep C Meds.Practical information on how you can ensure Hep C care and treatment is covered in NYC. Hep Free NYC.

Defining the HCV Experienced Provider. 2015. NYSDOH AIDS Institute.

NYS Hepatitis C Virus Approved Prescriber List. 2015. NYS DOH Medicaid Drug Utilization Review Board.

Smartphone app to identify hepatic encephalopathy in 5 mins.
>> See more Tools & Resources

Reports

City Health Information (CHI) | Diagnosing and Managing Hepatitis C. NYC Health Dept, Revised 2015.

Provider Reporting: How to Report Diseases, Events & Conditions to the NYC Health Dept. NYC Health Dept, 2015.

CDC MMWR | Hepatitis B Screening and Prevalence Among Resettled Refugees — United States, 2006–2011.

CDC | National Center for HIV/AIDS, Viral Hepatitis, STD & TB Prevention Strategic Plan through 2020

2013 NYC Hepatitis B & C Surveillance Report. NYC Health Dept, 2015. See also EpiQuery, NYC Health Dept online data portal.

Abstracts, Presentations, and Posters | 2015 National Summit on HCV and HIV Diagnosis, Prevention and Access to Care.

Articles

Factors Associated With HCV Infection Among HIV-Infected MSM With No Reported Injection Drug Use, NY (2000-2010). Sexually Transmitted Diseases, 2015. Researchers found a racial/ethnic disparity in HCV diagnosis rates and an association between HCV and syphilis, which is consistent with sexual transmission of HCV. With curative HCV treatment available, emphasis should be placed on adherence to guidelines recommending annual HCV screening for HIV-infected MSM, and education and outreach to MSM to prevent sexually transmitted HCV infections.

Restrictions for Medicaid Reimbursement of Sofosbuvir for the Treatment of Hepatitis C Virus Infection in the United States. Annals of Internal Medicine, 2015. The aim of this study was to systematically evaluate state Medicaid policies for the treatment of hepatitis C virus (HCV) infection with sofosbuvir in the United States. Medicaid reimbursement criteria for sofosbuvir were evaluated in all 50 states and the District of Columbia. 

Tackling the Health Challenge posed by Hepatitis C in Puerto Rico. Puerto Rico Health Sciences Journal. In 2010-2011, the Puerto Rico Department of Health documented that the most prevalent chronic infection in their correctional institutions was hepatitis C (54.6%).

Can HIV and HCV Infection be Eliminated among Persons who Inject Drugs? J Addict Dis. 2015.

Underascertainment of Acute Hepatitis C Virus Infections in the U.S. Surveillance System: A Case Series and Chart Review. Annals of Internal Medicine, 2015. Clinical diagnoses of acute HCV infection were grossly underascertained by formal surveillance reporting. Incomplete clinician reporting, problematic case definitions, limitations of diagnostic testing, and imperfect data capture remain major limitations to accurate case ascertainment despite automated electronic laboratory reporting. These findings may have implications for national estimates of the incidence of HCV infection.

Incidence and prevalence of Hep C among PWID in NYC: 2006-2013. Drug Alcohol Depend. 2015. HCV prevalence among PWID (N:1535) was 67% during the study period.

Online Training

Health Literacy for Health Professionals Online Training. CDC.

Hep C Capacity to Cure Weekly Tele-medicine sessions by Empire Liver Foundation hepatologists. For MD, NP and PAs only. Learn more and join.

HepCure Tele-Education Weekly Webinars. Mount Sinai. View webinar archives here.

Hepatitis C Clinical Consultation Line: NYS DOH Clinical Education Initiative

Online CEU | The Prevalence of Prescription Opioid Misuse: Doctor Shopping, Co-ingestion, and Exposure. Self paced online course.

Online CME/CE/CPE | Post Conference HCV Update: 50th Annual Meeting of the European Association for the Study of the Liver. Practice Point CME.

Action Alerts


Ask Congress to End the Federal Ban on Funding for Syringe Exchange. AIDS United Policy Action Center. Syringe exchange is Hep C prevention. 

Survey | United Nations General Assembly Special Session on Drugs (Due July 31)

Survey | For Hepatitis C Providers. HealthHCV inaugural State of HCV Care national survey in partnership with Medscape for medical providers nationwide. 

Join: NY State Hepatitis C Coalition to engage in NYS advocacy.

Join: National Viral Hepatitis Roundtable to engage in national advocacy.

Join: World Hepatitis Alliance to engage in global advocacy.
>> See more Action Alerts

Job Board


Viral Hepatitis Prevention Coordinator @ NYC Health Dept

Hep C Patient Navigator/Outreach Worker @ Mount Sinai Primary Care Hep C Program

Hepatitis Program Assistant @ National Viral Hepatitis Roundtable

HIV/Hep C Client Navigator @ Turning Point

Outreach & Syringe Exchange Specialist @ NY Harm Reduction Educators

Data Manager @ Mount Sinai Hep C Program

Project Coordinator for Hep C Screening & Link to Care @ Mount Sinai

>> More jobs here.

Funding Board

 
Health Care Access for HIV/HCV People Who Inject Drugs (Janssen Therapeutics) (rolling due dates)
>> More funding opportunities here.

Join our network!

NYC Liver Health
@HepFreeNYC
Hep Free NYC
View our Hep Free NYC Partner Profiles!
Since 2007, this Newsletter has been developed through information, resources and opportunities shared by our Hep B Coalition and Hep C Task Force partners. Thank you! To send your ideas, click here
Share
Tweet
Share
Copyright © 2015 NYC Health Department, All rights reserved.


unsubscribe from this list    update subscription preferences